Signal active
Contact Information
Social
Primary Organization
2015
11-50
Biotechnology, Life Science, Health Care, Biopharma, Therapeutics
Bio
In 2015, together with Daniel OLIVE and Alem TRUNEH, Benjamin CHARLES cofounded ImCheck Therapeutics.
Today, he is a Board Member of the Company and its Chief Business Officer, bringing 10 years of experience in Business Development and Strategy.
In 2008, Benjamin CHARLES started his career in healthcare consulting and mergers & acquisitions, firstly at BNP Paribas Corporate Finance, and then at AEC Partners and Publicis Healthcare, Paris. Benjamin advised pharmaceuticals companies as well as SMEs on strategic planning, business development, market access, and medical affairs assignments. Benjamin joined Inserm Transfert in 2012 where he took responsibility for the oncology portfolio, out-licensing biomarkers and therapeutic compounds to pharmaceutical companies and startups, including in the fields of Immune-modulation and therapeutic antibodies.
Benjamin holds a doctorate in Pharmaceutical Sciences and an MBA from Essec Business School; he also is a member of the chair of bioethics and therapeutic innovation and of the chair Essec Santé.
Location
Paris, Ile-de-France, France, Europe
Jobs history
1
DiogenX
Chief Executive Officer - Co-founder
2019 - Current
Educations
1
N/A
Profile Resume
Benjamin Charles is the Chief Business Officer at ImCheck Therapeutics, based in Europe. With a background in Biotechnology, Benjamin Charles has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.